Northern Trust’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-13,033
Closed -$45.1K 4559
2023
Q1
$45.1K Hold
13,033
﹤0.01% 4285
2022
Q4
$54.5K Sell
13,033
-742
-5% -$2.81K ﹤0.01% 4266
2022
Q3
$56K Sell
13,775
-3,328
-19% -$25.2K ﹤0.01% 4295
2022
Q2
$193K Sell
17,103
-70,364
-80% -$844K ﹤0.01% 3950
2022
Q1
$1.42M Buy
87,467
+3,113
+4% +$79.8K ﹤0.01% 3262
2021
Q4
$4M Buy
84,354
+21,140
+33% +$1.27M ﹤0.01% 2823
2021
Q3
$4.58M Sell
63,214
-14,793
-19% -$1.07M ﹤0.01% 2783
2021
Q2
$6.55M Buy
+78,007
New +$5.15M ﹤0.01% 2670

Other funds holding NBP

Northern Trust's NBP Position: Q2 2023 in Review

Northern Trust sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2023, closing a stake of 13,033 shares — an estimated $45.1K sold.

Northern Trust first reported a position in NBP in Q2 2021 and held it in 8 quarters. The position peaked at $6.55M in Q2 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q2 2023.

  • Northern Trust reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q2 2023 after selling out during the quarter.
  • Northern Trust sold 13,033 NovaBridge Biosciences American Depositary Shares shares in Q2 2023, an estimated $45.1K.
  • Northern Trust first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 8 quarters.
  • Northern Trust's NovaBridge Biosciences American Depositary Shares position peaked at $6.55M in Q2 2021.
  • 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2023.

Based on Northern Trust's 13F filing for Q2 2023, filed 11 Aug 2023.